Total planned funding: $35,557,898
Clear active filters
Other USG Agency
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Zambia | $4,660,490 |
| Uganda | $4,600,368 |
| Mozambique | $4,309,693 |
| South Africa | $3,679,935 |
| Ukraine | $2,920,000 |
| Malawi | $2,514,599 |
| Eswatini | $2,044,895 |
| Ethiopia | $1,647,396 |
| Lesotho | $1,348,000 |
| Tanzania | $1,151,703 |
| Zimbabwe | $996,000 |
| Botswana | $745,275 |
| Kenya | $697,742 |
| Central America Region | $640,169 |
| Cameroon | $542,179 |
| Ghana | $510,000 |
| Caribbean Region | $500,000 |
| Asia Regional Program | $446,448 |
| Democratic Republic of the Congo | $326,094 |
| Guyana | $323,464 |
| Namibia | $247,746 |
| Rwanda | $238,118 |
| Dominican Republic | $225,000 |
| Côte d'Ivoire | $94,584 |
| Papua New Guinea | $85,000 |
| Indonesia | $25,000 |
| Haiti | $24,000 |
| Vietnam | $14,000 |
| South Sudan | $0 |
| Central Asia Region | $0 |
Organizational Types
| Other USG Agency | $35,557,898 |
Program Areas
| Care | $10,952,241 |
| Governance and Systems | $10,905,098 |
| Prevention | $7,934,413 |
| Treatment | $5,351,308 |
| Testing | $414,838 |
Budget Codes
| HKID: Care: Orphans and Vulnerable Children | $6,333,486 |
| HLAB: Laboratory Infrastructure | $5,478,502 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $5,124,008 |
| HTXS: Treatment: Adult Treatment | $4,855,403 |
| OHSS: Health Systems Strengthening | $4,326,942 |
| HBHC: Care: Adult Care and Support | $3,356,171 |
| HVTB: Care: TB/HIV | $1,107,011 |
| HVSI: Strategic Information | $1,099,654 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $872,707 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $709,418 |
| HMBL: Biomedical Prevention: Blood Safety | $655,258 |
| PDTX: Treatment: Pediatric Treatment | $495,905 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $449,522 |
| HVCT: Testing: HIV Testing and Counseling | $414,838 |
| PDCS: Care: Pediatric Care and Support | $155,573 |
| HMIN: Biomedical Prevention: Injection Safety | $123,500 |
| HTXD: Treatment: ARV Drugs | $0 |